(Q44636524)

4 December 2017

title

Drug Resistance Profiles of Recombinant Reverse Transcriptases from Human Immunodeficiency Virus Type 1 Subtypes A/E, B, and C (English)

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

26 March 2024

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

26 March 2024

4

Max Essex

1 reference

4 December 2017

6

Mark A Wainberg

1 reference

4 December 2017

5

Takashi Kurimura

1 reference

4 December 2017

Yudong Quan

1

1 reference

4 December 2017

Bluma G. Brenner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585205

26 March 2024

Richard G. Marlink

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585205

26 March 2024

Mark A. Wainberg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585205

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14585205

26 March 2024

publication date

1 September 2003

1 reference

full work available at URL

4 December 2017

http://www.liebertpub.com/doi/pdf/10.1089/088922203769232548

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

AIDS Research and Human Retroviruses

26 March 2024

published in

1 reference

4 December 2017

volume

19

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

743-753

1 reference

Mechanisms of retroviral mutation

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

The accuracy of reverse transcriptase from HIV-1.

26 March 2024

2

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Perspectives series: host/pathogen interactions. Dynamics of HIV-1 replication in vivo

26 March 2024

3

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

High rate of recombination throughout the human immunodeficiency virus type 1 genome

26 March 2024

4

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Human immunodeficiency virus type 1 clade A and D neurotropism: molecular evolution, recombination, and coreceptor use.

26 March 2024

5

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Phylogenetic reconstruction of intrapatient evolution of human immunodeficiency virus type 1: predominance of drift and purifying selection

26 March 2024

7

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy

26 March 2024

8

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

26 March 2024

12

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy

26 March 2024

13

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

HIV-1 nomenclature proposal.

26 March 2024

14

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Genotypic testing for human immunodeficiency virus type 1 drug resistance

26 March 2024

16

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

26 March 2024

17

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

26 March 2024

18

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

26 March 2024

19

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypes

26 March 2024

20

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.

26 March 2024

22

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase

26 March 2024

23

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography.

26 March 2024

24

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Dominance of the E89G substitution in HIV-1 reverse transcriptase in regard to increased polymerase processivity and patterns of pausing

26 March 2024

25

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine

26 March 2024

27

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.

26 March 2024

28

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

26 March 2024

29

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies

26 March 2024

30

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

26 March 2024

31

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA

26 March 2024

32

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Evidence of a role for the Q151L mutation and the viral background in development of multiple dideoxynucleoside-resistant human immunodeficiency virus type 1

26 March 2024

33

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine

26 March 2024

34

1 reference

https://api.crossref.org/works/10.1089/088922203769232548

26 March 2024

Identifiers

1 reference

4 December 2017

1 reference